Bellevue Life Sciences Acquisition Corp. (BLAC )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol BLAC
- Company Bellevue Life Sciences Acquisition Corp.
- Price $3.01
- Changes Percentage -55.27
- Change -3.72
- Day Low $3.01
- Day High $4.43
- Year High $13.4
- Year Low $3.01
- Market Cap $6,982,448
- Price Avg 50 EMA (D) $10.74
- Price Avg 200 EMA (D) $10.87
- Exchange NASDAQ
- Volume 430,774
- Average Volume 15,258
- Open $3.89
- Previous Close $6.73
- EPS -0.09
- PE -33.44
- Earnings Announcement 1970-01-01 00:00:00
- Shares Outstanding $2,319,750
Company brief: BELLEVUE LIFE SCIENCES ACQUISITION CORP. (BLAC )
- Financial Services
- Shell Companies
- Mr. Kuk Hyoun Hwang
- US
- N/A
- 03-21-2023
- US0791741087
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.